States v. the FDA: Telemedicine and Mifepristone

An event discussing how FDA policy regarding telemedicine and mifepristone affects a state’s ability to regulate abortion with commentary from Prof. Michael Moreland.

*******

As always, the Federalist Society takes no position on particular legal or public policy issues; all expressions of opinion are those of the speaker.